FN Clarivate Analytics Web of Science
VR 1.0
PT J
DE siRNA; gene silencing; RNA interference; cancer therapy
ID DOUBLE-STRANDED-RNA; RIG-I ACTIVATION; LIPID NANOPARTICLES; TARGETED
   DELIVERY; CATIONIC LIPIDS; SIRNA; THERAPEUTICS; EFFICACY; CELLS;
   DOXORUBICIN
ER

PT J
ER

PT J
DE cancer therapy; DNA nanotechnology; drug delivery; multidrug resistance;
   RNAi therapy
ID P-GLYCOPROTEIN; CANCER; DRUG; DELIVERY; SIRNA; NANOSTRUCTURES; ORIGAMI;
   GENE; CIRCUMVENTION; NANOPARTICLES
ER

PT J
ID FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; GENE-THERAPY; MOUSE MODEL;
   HUNTINGTONS-DISEASE; CANDIDATE GENE; IN-VITRO; INTERFERENCE; DUX4;
   EXPRESSION; SHRNA
ER

PT J
DE cancer hallmarks; iron oxide nanoparticles; MRI; RNAi; tumor penetration
ID SYSTEMIC SIRNA DELIVERY; LIPID NANOPARTICLES; PROSTATE-CANCER; IRON;
   HYPOXIA; THERAPEUTICS; METABOLISM; ACTIVATION; TUMOR; CELL
ER

PT J
DE Lung cancer; biomarkers; nanocarriers; RNAi-based therapy
ID SOLID LIPID NANOPARTICLES; P85-PEI/TPGS COMPLEX NANOPARTICLES; RISK
   PREDICTION MODEL; GENE DELIVERY; CO-DELIVERY; SYSTEMIC DELIVERY;
   IN-VIVO; MOLECULAR-BIOLOGY; DOWN-REGULATION; SIRNA DELIVERY
ER

PT J
DE RNAi; shRNA; siRNA; Huntington's disease; Off-target effects;
   Huntingtin; Silencing
ID LENTIVIRUS-MEDIATED RNAI; GENE-THERAPY; MUTANT HUNTINGTIN; MOUSE MODEL;
   DELIVERY; BRAIN; PHOSPHORYLATION; POTENT; MOTOR; MICE
ER

PT J
DE RNAi; Glioblastoma; GBM; Nanoparticles; Mouse models
ID BLOOD-BRAIN-BARRIER; CONJUGATED GOLD NANOPARTICLES; IN-VITRO; SIRNA
   DELIVERY; MAMMALIAN-CELLS; SOLID TUMORS; CHEMICAL-MODIFICATIONS;
   DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; TARGETED NANOPARTICLES
ER

PT J
DE Nanocarriers; RNAi; siRNA; miRNA; Cancer therapy; Gene therapy
ID EXOSOME-MIMETIC NANOVESICLES; SIRNA DELIVERY; GOLD NANOPARTICLES;
   MEDIATED DELIVERY; VIRAL VECTORS; GENE DELIVERY; IN-VIVO; INTERFERENCE
   RNAI; IMMUNE-RESPONSES; SOLID TUMORS
ER

PT J
ID IN-VIVO DELIVERY; ENHANCES ANTITUMOR IMMUNITY; LIPID NANOPARTICLE
   SYSTEMS; SUPPRESSES HIV-1 INFECTION; CD8(+) T-CELLS; SIRNA DELIVERY;
   GENE DELIVERY; CATIONIC LIPIDS; HUMANIZED MICE; CLINICAL-APPLICATIONS
ER

PT J
DE Lipid nanoparticles; Exosomes; Extracellular vesicles; targeted
   delivery; RNAi; siRNA; Cationic lipid
ID SMALL-INTERFERING-RNA; MEDIATED SIRNA DELIVERY; LIPID-BASED
   NANOPARTICLES; CELL-PENETRATING PEPTIDE; IN-VIVO DELIVERY; SPHERICAL
   NUCLEIC-ACIDS; INNATE IMMUNE-RESPONSE; NONVIRAL GENE DELIVERY;
   CANCER-THERAPY; SYSTEMIC DELIVERY
ER

PT J
DE Antithrombotic therapy; Thrombosis; Pharmacology
ER

PT J
DE near-infrared light response; SWNT; RNAi; Hsp70B' promoter
ID BREAST-CANCER; PHOTOTHERMAL THERAPY; SIRNA DELIVERY; PROMOTER; HTERT;
   CELLS; NANOPARTICLES; EXPRESSION; SYSTEMS; LIGHT
ER

PT J
DE RNA interference; RNAi; Kidney stone; Nephrolithiasis; Primary
   hyperoxaluria; Oxalate; Glycolate oxidase; Hydroxyproline; Idiopathic
   calcium oxalate; Hydroxyproline dehydrogenase; Endogenous oxalate
ID PRIMARY HYPEROXALURIA; GLYCOLATE OXIDASE; HYDROXYPROLINE DEHYDROGENASE;
   N-ACETYLGALACTOSAMINE; HEPATOCYTES; INHIBITION; METABOLISM
ER

PT J
DE Molecular imaging; Cancer; Nanocarrier; siRNA; RNA interference; Gene
   delivery; Theranostics
ID MEDIATED SIRNA DELIVERY; POSITRON-EMISSION-TOMOGRAPHY; ENDOTHELIAL
   GROWTH-FACTOR; TARGETED DRUG-DELIVERY; ADVANCED SOLID TUMORS; IN-VIVO;
   GENE DELIVERY; SYSTEMIC DELIVERY; CANCER-THERAPY; CONTRAST AGENTS
ER

PT J
ID ANTIAPOPTOTIC CELLULAR DEFENSE; SINGLE-STRANDED RNA; MESOPOROUS SILICA
   NANOPARTICLES; OVERCOME DRUG-RESISTANCE; MULTIDRUG-RESISTANCE;
   P-GLYCOPROTEIN; CO-DELIVERY; BREAST-CANCER; IN-VITRO; GENE DELIVERY
ER

PT J
ER

PT J
DE Host-directed therapy; Inhalation; MicroRNA; Non-viral vectors;
   Pulmonary delivery; RNAi delivery; Small interfering RNA; Tuberculosis
ID RESPIRATORY SYNCYTIAL VIRUS; SMALL INTERFERING RNA; HOST-DIRECTED
   THERAPIES; SIRNA DELIVERY-SYSTEM; PLASMINOGEN-ACTIVATOR INHIBITOR-1;
   MULTIDRUG-RESISTANT TUBERCULOSIS; PH-RESPONSIVE PEPTIDES; DRY POWDER
   FORMULATION; MYCOBACTERIUM-TUBERCULOSIS; DRUG-DELIVERY
ER

PT J
DE cancer therapy; nanoparticles; pH-responsive; siRNA delivery; tumor
   penetration
ID NONVIRAL VECTORS; DRUG-DELIVERY; NANOPARTICLES; THERAPY
ER

PT J
DE Cancer therapeutics; KRAS; MYC; RNAi; siRNAs; synthetic lethality
ID NEGATIVE BREAST-CANCER; IN-VIVO; MEDIATED DELIVERY; KRAS MUTATIONS;
   SIRNA; THERAPY; RESISTANCE; SCREEN; INTERFERENCE; INHIBITION
ER

PT J
ID TUMOR-ASSOCIATED MACROPHAGES; HUMAN DENDRITIC CELLS; REGULATORY T-CELLS;
   IN-VIVO DELIVERY; SIRNA DELIVERY; SUPPRESSOR-CELLS; PLGA NANOPARTICLES;
   INTERFERING RNA; BREAST-CANCER; STAT3 SIRNA
ER

PT S
DE clinical trials; siRNA; miRNA; shRNA; dsiRNA
ID DOUBLE-STRANDED-RNA; CHRONIC HEPATITIS-B; NONHUMAN-PRIMATES; SIRNA
   DELIVERY; RIG-I; STRATEGIES; INFECTION; EFFICACY; MICE
ER

PT J
DE RNA interference; long QT syndrome; dominant-negative suppression; gene
   therapy; induced pluripotent stem cells
ID PROTEIN TRAFFICKING; CARDIAC-ARRHYTHMIA; CHANNEL CURRENTS;
   HEART-FAILURE; HERG CURRENT; THERAPY; MUTATIONS; MECHANISM; RESCUES;
   CARDIOMYOCYTES
ER

PT J
ID EFFICIENT INTRACELLULAR DELIVERY; CONVECTION-ENHANCED DELIVERY; CARBON
   NANOTUBES; IN-VITRO; LIPID NANOCAPSULES; SIRNA DELIVERY; CANCER-THERAPY;
   GENE-THERAPY; GOLD NANOPARTICLES; MICRORNA DELIVERY
ER

PT J
ER

PT J
DE Self-assembled nanoparticle; RNAi; Tumor-homing and penetrating; iNGR;
   Glutathione triggered; Glioma therapy
ID CANCER-THERAPY; AMINOPEPTIDASE N; DRUG-DELIVERY; GENE DELIVERY; PEPTIDE;
   GOLD; VIVO; MICROENVIRONMENT; INTERFERENCE; VASCULATURE
ER

PT J
DE drug delivery; leukemia; molecular therapy; nonviral vectors;
   nanoparticles; RNAi; siRNA
ID ACUTE MYELOGENOUS LEUKEMIA; TARGETED GENE DELIVERY; SMALL INTERFERING
   RNA; CHRONIC LYMPHOCYTIC-LEUKEMIA; CML STEM/PROGENITOR CELLS; IN-VIVO
   DELIVERY; BCR-ABL GENE; MYB ANTISENSE OLIGODEOXYNUCLEOTIDES; ACUTE
   MEGAKARYOBLASTIC LEUKEMIA; RISK MYELODYSPLASTIC SYNDROME
ER

PT J
ID SMALL INTERFERING RNA; RESPIRATORY SYNCYTIAL VIRUS; DOUBLE-STRANDED-RNA;
   IN-VIVO; SIRNA DELIVERY; MEDIATED DELIVERY; TUMOR-GROWTH;
   FUTURE-PROSPECTS; MAMMALIAN-CELLS; DOWN-REGULATION
ER

PT J
DE RNAi; delivery vehicle; pharmaceutical companies; nanotechnology;
   biomaterials
ID SIRNA DELIVERY; DESIGN; POTENT
ER

PT J
ID NITRIC-OXIDE SYNTHASE; HEPATITIS-C VIRUS; APTAMER-SIRNA CHIMERAS;
   DOUBLE-STRANDED-RNA; IN-VIVO; GENE-REGULATION; ENDOTHELIAL-CELLS;
   NONHUMAN-PRIMATES; TARGETED THERAPY; LDL CHOLESTEROL
ER

PT J
DE RNAi therapeutics; siRNA delivery; Barriers; Off-target effect; Clinical
   trials
ID SMALL INTERFERING RNA; CELL-PENETRATING PEPTIDES; ENHANCED ENDOSOMAL
   ESCAPE; LIPID-LIKE MATERIALS; IN-VIVO DELIVERY; CHEMICAL-MODIFICATION;
   MEDIATED ENDOCYTOSIS; POLYMERIC MICELLES; GENE KNOCKDOWN; DRUG-DELIVERY
ER

PT J
DE cancer therapy; gene silencing; RNAi; update
ID LONG NONCODING RNAS; INNATE IMMUNE-RESPONSE; HEPATOCELLULAR-CARCINOMA;
   IN-VIVO; TRANSCRIPTION FACTORS; SYNTHETIC SIRNA; DRUG-DELIVERY;
   HUMAN-DISEASE; CELL-GROWTH; NANOPARTICLES
ER

PT J
DE Rnai; Shrna; Sirna; Antiviral Therapy; Animal Virus
ER

PT J
DE Multidrug resistant microorganism; RNA interference; Nanoantibiotics
ID MULTIDRUG-RESISTANCE; GOLD NANOPARTICLES; GENE DELIVERY; ANTIMICROBIAL
   PEPTIDES; BACTERIAL-RESISTANCE; P-GLYCOPROTEIN; PLASMID DNA; IN-VITRO;
   INTERFERENCE; ANTIBIOTICS
ER

PT J
DE Gastric cancer; RNAi; gene therapy; inhibiting effect
ID MULTIDRUG-RESISTANCE; DOWN-REGULATION; MESSENGER-RNA; IN-VIVO;
   MAMMALIAN-CELLS; CARCINOMA CELLS; GENE; EXPRESSION; SIRNA; INHIBITION
ER

PT J
ID PROTEIN-KINASE CK2; HUMAN PROSTATE-CANCER; ANTISENSE OLIGONUCLEOTIDES;
   TENASCIN-C; IN-VIVO; HEAD; GENE; INDUCTION; APOPTOSIS; IDENTIFICATION
ER

PT J
DE cancer; nanomedicine; oncogene addiction; RNAi delivery; targeted
   therapy
ID GROWTH-FACTOR RECEPTOR; VIRUS-LIKE PARTICLES; CHRONIC MYELOID-LEUKEMIA;
   APTAMER-SIRNA CHIMERAS; CELL-SPECIFIC DELIVERY; ROUS-SARCOMA-VIRUS;
   PHILADELPHIA-CHROMOSOME; DRUG-DELIVERY; CHEMICAL-MODIFICATION;
   MULTIPLE-MYELOMA
ER

PT J
ID IN-VIVO; SIRNA DELIVERY; CANCER; NANOPARTICLES; GENE; THERAPEUTICS;
   EFFICACY; TUMORS
ER

PT J
ID TUMOR-NECROSIS-FACTOR; CELL LUNG-CANCER; MODULATES MULTIDRUG-RESISTANCE;
   HUMAN HEPATOCELLULAR-CARCINOMA; THYROID PAPILLARY CARCINOMAS; CHRONIC
   LYMPHOCYTIC-LEUKEMIA; HUMAN BREAST-CANCER; ANTAGONIST KILLER 1; C-KIT
   RECEPTOR; PROSTATE-CANCER
ER

PT J
DE RNAi; PDX1; pancreatic cancer
ID RESPIRATORY SYNCYTIAL VIRUS; TYPE-2 DIABETES-MELLITUS; FACTOR-I GENE;
   MACULAR DEGENERATION; DUODENAL HOMEOBOX-1; K-RAS; MISSENSE MUTATIONS;
   INTERFERENCE RNAI; PROGENITOR CELLS; EXPRESSION
ER

PT B
ID THERAPEUTICS; INTERFERENCE; SYL040012; GLAUCOMA
ER

PT J
DE delivery vectors; gene therapy; HBV; RNAi; siRNA
ID HEPATITIS-B-VIRUS; REPLICATION IN-VIVO; ALTRITOL-MODIFIED SIRNAS;
   MEDIATED GENE-TRANSFER; ZINC-FINGER NUCLEASES; CIRCULAR VIRAL-DNA; SHORT
   HAIRPIN RNAS; MESSENGER-RNA; HEPATOCELLULAR-CARCINOMA; POSTEXPOSURE
   PROTECTION
ER

PT J
DE RNAi; leukocytes; integrins; nanoparticles; liposomes
ID SMALL INTERFERING RNA; LIPID-BASED NANOPARTICLES; MANTLE-CELL LYMPHOMA;
   IN-VIVO DELIVERY; IMMUNE-RESPONSE; SIRNA DELIVERY; CYCLIN D1;
   CHEMICAL-MODIFICATION; PEGYLATED LIPOSOMES; DENDRITIC CELLS
ER

PT S
ID INHIBITS TUMOR-GROWTH; HUMAN PROSTATE-CANCER; IN-VIVO; GENE DELIVERY;
   BIOMEDICAL APPLICATIONS; SIRNA DELIVERY; OVARIAN-CARCINOMA; PAMAM
   DENDRIMERS; CERVICAL-CANCER; DRUG-DELIVERY
ER

PT J
DE cancer therapy; cell death; cell survival; RNAi
ID SMALL INTERFERING RNA; ENDOTHELIAL GROWTH-FACTOR; HUMAN GLIOMA-CELLS;
   CELLULAR SENESCENCE; MULTIDRUG-RESISTANCE; INDUCED SUPPRESSION;
   CARCINOMA-CELLS; IN-VITRO; SIRNA; APOPTOSIS
ER

PT J
DE Short interfering RNA (siRNA); In vivo; Systemic delivery;
   Nanoparticles; Clinical trials; Personalized medicine
ID SMALL INTERFERING RNA; MEDIATED SIRNA DELIVERY; LIPID-LIKE MATERIALS;
   SHORT HAIRPIN RNA; IN-VIVO DELIVERY; MAMMALIAN-CELLS; GENE-EXPRESSION;
   CHEMICAL-MODIFICATION; NONHUMAN-PRIMATES; CARBON NANOTUBES
ER

PT J
ER

PT J
ER

PT J
DE Disease; Gene; Research; RNAi; Therapeutics
ID SHORT HAIRPIN RNA; ADULT-MOUSE BRAIN; HEPATITIS-B-VIRUS; VECTOR-BASED
   RNAI; MAMMALIAN-CELLS; IN-VIVO; TRANSGENIC MICE; EXPRESSION VECTORS;
   MEDIATED DELIVERY; METASTATIC TUMORS
ER

PT J
ID NF-KAPPA-B; SHORT HAIRPIN RNAS; T-CELL-ACTIVATION; ANTIRETROVIRAL
   THERAPY; INTERFERENCE; ESCAPE; IDENTIFICATION; REPLICATION; MICROARRAY;
   INITIATION
ER

PT J
DE RNA interference; delivery systems; liposome; nanoparticle; molecular
   medicines
ID SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; DNA PACKAGING MOTOR; GOLD
   NANOPARTICLES; MAMMALIAN-CELLS; SIRNA DELIVERY; MESSENGER-RNA;
   BACTERIOPHAGE-PHI-29 DNA; GASTRIC-CANCER; IN-VIVO
ER

PT J
DE cancer therapy; delivery; RNA interference
ID SILENCING IN-VITRO; MAMMALIAN-CELLS; GENE-EXPRESSION; ANTITUMOR
   IMMUNITY; DENDRITIC CELLS; CAENORHABDITIS-ELEGANS; ANTIGEN PRESENTATION;
   MICRORNA EXPRESSION; PANCREATIC-CANCER; SYSTEMIC DELIVERY
ER

PT J
ID SEX-LETHAL; GENE; TRANSDUCTION; DELIVERY; DOMAIN
ER

PT J
ER

PT J
DE RNAi; shRNA; siRNA; therapy
ID DOUBLE-STRANDED-RNA; EMBRYONIC STEM-CELLS; HEPATITIS-C VIRUS; IN-VIVO;
   TRANSGENIC MICE; SIRNA DELIVERY; MOUSE OOCYTES; ADULT MICE; MEDIATED
   TRANSFER; MESSENGER-RNAS
ER

PT J
ID HEPATITIS-C VIRUS; DOUBLE-STRANDED-RNA; CENTRAL-NERVOUS-SYSTEM;
   OFF-TARGET ACTIVITY; SHORT HAIRPIN RNAS; IN-VIVO DELIVERY; SIRNA
   DELIVERY; MESSENGER-RNA; GENE-TRANSFER; NONHUMAN-PRIMATES
ER

PT J
ER

PT J
ID SMALL INTERFERING RNA; DISEASE MOUSE MODEL; SHORT HAIRPIN RNAS;
   HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; IN-VIVO; ALPHA-SYNUCLEIN;
   MAMMALIAN-CELLS; SPINOCEREBELLAR ATAXIA; MUTANT HUNTINGTIN
ER

PT S
DE RNA interference; siRNA; cationic lipid; gene therapy
ID SHORT-INTERFERING RNAS; TUMOR-BEARING MICE; PEG IGM PRODUCTION; SIRNA
   DELIVERY; POLY(ETHYLENE GLYCOL); NONVIRAL VECTORS; MAMMALIAN-CELLS;
   GENE-EXPRESSION; INTRACELLULAR DELIVERY; CLEAVABLE LIPOPOLYMERS
ER

PT S
ID HUMAN-IMMUNODEFICIENCY-VIRUS; SHORT HAIRPIN RNAS; HUMAN IMMUNE-SYSTEM;
   HEPATITIS-B-VIRUS; GENE-THERAPY; LENTIVIRAL VECTOR; MAMMALIAN-CELLS;
   HOST FACTORS; MOUSE MODEL; IN-VIVO
ER

PT J
DE adenovirus; helper-dependent adenovirus; hepatitis B virus; hepatitis C
   virus; RNA interference
ID HEPATITIS-B-VIRUS; REPLICATION IN-VIVO; HELPER-DEPENDENT ADENOVIRUS;
   SHORT HAIRPIN RNA; SMALL INTERFERING RNAS; GENE-TRANSFER; HBV
   REPLICATION; HEPATOCELLULAR-CARCINOMA; ADENOASSOCIATED VIRUS; EFFICIENT
   INHIBITION
ER

PT J
DE RNAi; Chemical stability; Delivery; Gene silencing
ER

PT J
DE small interfering RNA; gene expression; gene therapy; autoimmune
   diseases
ER

PT J
DE RNAi therapeutics; Angiogenesis; Endothelial dysfunction; Atu027
ID SIRNA DELIVERY; PHENOTYPIC HETEROGENEITY; MURINE ARTHRITIS;
   MAMMALIAN-CELLS; GENE-THERAPY; ANGIOGENESIS; PERMEABILITY; MECHANISMS;
   TARGET; CANCER
ER

PT J
ID SUPPRESSES TUMOR-GROWTH; DOUBLE-STRANDED-RNA; IN-VIVO; TARGETED
   NANOPARTICLES; CELL-PROLIFERATION; STRUCTURAL BASIS; CARCINOMA CELLS;
   SIRNA DELIVERY; NUDE-MICE; EXPRESSION
ER

PT J
DE RNAi; Therapy; Neurodegenerative; Huntington's; Alzheimer's;
   Parkinson's; Ataxias
ID SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; POLYGLUTAMINE-INDUCED
   NEURODEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; SCA1 TRANSGENIC MICE;
   HUNTINGTONS-DISEASE; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PROLONGS
   SURVIVAL; MEDIATED RNAI
ER

PT J
ID CULTURED-MAMMALIAN-CELLS; INNATE IMMUNE-RESPONSE; HUMAN GLIOMA-CELLS;
   IN-VIVO; DENDRITIC CELLS; BRAIN-TUMORS; GENE-THERAPY; HAIRPIN RNA;
   SIRNA; MULTIFORME
ER

PT J
ID SMALL INTERFERING RNA; OVARIAN-CANCER; MURINE LIVER; DELIVERY;
   EXPRESSION; MICRORNAS; GROWTH; ADENOCARCINOMA; TARGETS; POTENT
ER

PT J
DE RNAi; siRNA; cancer; PLK-1; DDS; liposome; atelocollagen
ID POLO-LIKE-KINASE; CHRONIC MYELOID-LEUKEMIA; SQUAMOUS-CELL CARCINOMA;
   INDEPENDENT PROSTATE-CANCER; INHIBITS TUMOR-GROWTH; DOUBLE-STRANDED-RNA;
   LYMPH-NODE METASTASIS; NON-HODGKINS-LYMPHOMA; TOLL-LIKE RECEPTOR-3;
   ANTI-APOPTOSIS GENE
ER

PT J
DE Allergy; asthma; off-target effect; RNAi; siRNA; therapy
ID SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; ALLERGIC AIRWAY
   INFLAMMATION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B;
   SMOOTH-MUSCLE-CELLS; MURINE MODEL; MESSENGER-RNA; IN-VIVO;
   CPG-OLIGODEOXYNUCLEOTIDES
ER

PT J
DE bacteria-mediated RNAi; bm-RNAi; RNA interference; RNAi; shRNA; siRNA;
   therapeutic RNA; tkRNAi; transkingdom RNAi
ID HELICOBACTER-PYLORI UREASE; PROTEIN EXPRESSION THERAPY; TUMOR-TARGETED
   SALMONELLA; CULTURED-MAMMALIAN-CELLS; SHORT HAIRPIN RNAS; ATTENUATED
   SALMONELLA; IN-VIVO; STABLE EXPRESSION; ADULT VOLUNTEERS; GENE-TRANSFER
ER

PT J
DE HIV; RNAi; siRNA; targeted delivery; T-cell
ID THERAPEUTICS; INTERFERENCE
ER

PT J
ER

PT J
ID HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL INTERFERING RNAS;
   DOUBLE-STRANDED-RNA; POSTTRANSCRIPTIONAL REGULATORY ELEMENT; SHORT
   HAIRPIN RNAS; CENTRAL DNA FLAP; ANTIVIRAL DEFENSE-MECHANISM;
   MICRORNA-DESIGNED HAIRPINS; VIVO GENE DELIVERY; MAMMALIAN-CELLS
ER

PT J
DE Lipid; Liposome; Nanoparticles; siRNA; Systemic delivery; Endosome
   escape
ID SMALL INTERFERING RNA; INNATE IMMUNE-RESPONSE; DOUBLE-STRANDED-RNA;
   ENDOTHELIAL GROWTH-FACTOR; INHIBITS TUMOR-GROWTH; VIRUS TYPE-1
   REPLICATION; HUMAN PROSTATE-CANCER; TOLL-LIKE RECEPTOR-7; HUMAN
   BREAST-CANCER; VIVO GENE-TRANSFER
ER

PT J
DE Short hairpin RNA; In vivo delivery; Duration; Side effect; Hydrodynamic
   delivery
ID SHORT HAIRPIN RNA; B-VIRUS REPLICATION; COLON-CANCER CELLS; PLASMID DNA;
   IN-VIVO; MAMMALIAN-CELLS; BETA-CATENIN; EXPRESSION CASSETTES; DENDRITIC
   CELLS; BRAIN CANCER
ER

PT J
DE Conditional RNAi; Inducible RNAi; Transgenic RNAi; Cre/loxP;
   Tetracycline inducible system
ID INDUCIBLE SHRNA EXPRESSION; INTERFERENCE IN-VIVO; MAMMALIAN-CELLS;
   LENTIVIRAL VECTORS; CAENORHABDITIS-ELEGANS; SYSTEM; KNOCKDOWN; PROMOTER;
   CANCER; SIRNA
ER

PT J
ID AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; CU,ZN
   SUPEROXIDE-DISMUTASE; MEDIATED GENE-TRANSFER; MUTANT SOD1; ADENOVIRUS
   VECTORS; PROLONGS SURVIVAL; INTERFERING RNA; LINKED SOD1; MOUSE MODEL
ER

PT J
DE gene therapy; HCV; liver disease; miRNA; shRNA; siRNA
ID SMALL INTERFERING RNAS; ALPHA-2B PLUS RIBAVIRIN; MEDIATED GENE-TRANSFER;
   SHORT HAIRPIN RNA; ANTIVIRAL DEFENSE-MECHANISM; B-VIRUS REPLICATION;
   IN-VIVO; LIVER-TRANSPLANTATION; EFFICIENT TRANSDUCTION;
   CAENORHABDITIS-ELEGANS
ER

PT J
DE gene therapy; inflammation; rheumatoid arthritis; RNA interference
ID MURINE ARTHRITIS; MONOCYTES; DELIVERY; CELLS; MICE; THERAPEUTICS;
   INFLAMMATION; MACROPHAGES; INHIBITION; CYTOKINES
ER

PT J
DE delivery; RNA interference; RNAi; siRNA; systemic delivery; therapy
ID SMALL INTERFERING RNA; IN-VIVO DELIVERY; DOUBLE-STRANDED-RNA; ARGONAUTE
   SILENCING COMPLEX; MOUSE VASCULAR ENDOTHELIUM; NONHUMAN-PRIMATES;
   SYSTEMIC DELIVERY; MAMMALIAN-CELLS; NUCLEIC-ACIDS; GENE
ER

PT J
DE heart failure; RNA interference; gene therapy; hypertrophy; microRNAs
ID GENE-TRANSFER; IN-VIVO; SARCOPLASMIC-RETICULUM; DILATED CARDIOMYOPATHY;
   PHOSPHOLAMBAN; MODEL; CA2+; MICE; PHOSPHORYLATION; CARDIOMYOCYTES
ER

PT J
ER

PT J
DE antiviral; gene therapy; HIV-1; lentiviral vector; RNAi
ID IMMUNODEFICIENCY-VIRUS TYPE-1; SHORT HAIRPIN RNAS; SHORT INTERFERING
   RNAS; LENTIVIRAL VECTOR; HUMAN-CELLS; MAMMALIAN-CELLS; EFFECTIVE
   SUPPRESSION; T-LYMPHOCYTES; HUMAN GENOME; IN-VIVO
ER

PT J
DE RNAi; Neurons; RNAi therapy; Preclinical application; Neurodegenerative
   diseases; Review
ID SMALL INTERFERING RNA; AMYOTROPHIC-LATERAL-SCLEROSIS; 37-KDA/67-KDA
   LAMININ RECEPTOR; MOTOR-NEURON DEGENERATION; REGIONAL BRAIN ISCHEMIA;
   CENTRAL-NERVOUS-SYSTEM; PEPTIDE-BASED STRATEGY; DRUG TARGETING SYSTEM;
   DOUBLE-STRANDED-RNA; SHORT HAIRPIN RNAS
ER

PT S
DE HIV-1; RNAi; gene therapy; virus evolution; viral escape; combination
   therapy; lentiviral vector; HIS mouse
ID IMMUNODEFICIENCY-VIRUS TYPE-1; SHORT HAIRPIN RNAS; HUMAN-CELLS;
   LENTIVIRAL VECTOR; MAMMALIAN-CELLS; REVERSE-TRANSCRIPTASE; EFFECTIVE
   SUPPRESSION; MEDIATED INHIBITION; MOUSE MODEL; IN-VIVO
ER

PT J
DE Gene therapy; MicroRNA; Neurodegenerative diseases; RNA interference;
   RNAi; Viral vectors
ID DOUBLE-STRANDED-RNA; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; DYT1
   DYSTONIA; MEDIATED RNAI; GENE-THERAPY; MOUSE MODEL; IN-VIVO; MICRORNA
   PRECURSORS; PARKINSONS-DISEASE
ER

PT J
ER

PT J
DE CNS; neurodegenerative diseases; RNAi; RNAi delivery systems; RNAi
   therapeutics
ID BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; DOUBLE-STRANDED-RNA; NEURAL
   STEM-CELLS; GAMMA-SECRETASE INHIBITOR; SMALL INTERFERING RNA;
   TAY-SACHS-DISEASE; GENE-THERAPY; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE
ER

PT J
DE RNA interference; RNAi; siRNA; respiratory viruses; antiviral; therapy
ID SYNCYTIAL VIRUS-INFECTION; DOUBLE-STRANDED-RNA; CELLS; SIRNA;
   PALIVIZUMAB; POTENT
ER

PT J
DE allergy; RNAi; siRNA; shRNA; gene therapy; transcription factor;
   cytokine; susceptibility genes
ID DOUBLE-STRANDED-RNA; GLOBIN MESSENGER-RNA; SERUM IGE LEVELS;
   INTERLEUKIN-4 RECEPTOR; SINGLE-NUCLEOTIDE; MAMMALIAN-CELLS;
   ATOPIC-DERMATITIS; GENE-EXPRESSION; T-CELLS; AIRWAY HYPERRESPONSIVENESS
ER

PT J
ER

PT J
ID SEQUENCE-SPECIFIC KNOCKDOWN; SMALL INTERFERING RNA; IN-VIVO DELIVERY;
   PASSENGER-STRAND; MAMMALIAN-CELLS; MODIFIED SIRNAS; MESSENGER-RNA; GENE;
   CLEAVAGE; DICER
ER

PT J
DE atelocollagen; cancer; delivery; drug discovery; RNAi; therapy
ID CANCER
ER

PT J
DE conserved target sequences; H5N1; influenza; pandemic flu; RNAi; RNA
   interference; RNAi therapeutic; siRNA; small-interfering RNA
ID DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; GENE DELIVERY; IN-VIVO;
   INTERFERING RNA; GENOME REPLICATION; VIRUS-REPLICATION; AVIAN INFLUENZA;
   TRANSCRIPTION; PROTEIN
ER

PT S
ID ISCHEMIA-REPERFUSION INJURY; CAENORHABDITIS-ELEGANS; IN-VIVO; GENE;
   SIRNA; CELL; MICRORNAS; MICE; TECHNOLOGY; RESISTANCE
ER

PT J
DE RNA silencing; RNAi; suppressors; HIV-1; Ebola virus; influenza A virus;
   adenovirus
ID ANTIVIRAL DEFENSE-MECHANISM; BINDING PROTEIN; INTERFERENCE; MICRORNA;
   HIV-1; REPLICATION; CELLS; MODULATION; INFECTION; IMMUNITY
ER

PT J
DE RNAi; virus; evading; strategies
ID HIV-1; REPLICATION; SUPPRESSOR; ESCAPE; GENOME; SIRNA
ER

PT J
DE biotherapy; inflammation; rheumatoid arthritis; RNA interference; TNF
   alpha
ID SMALL INTERFERING RNA; COLLAGEN-INDUCED ARTHRITIS; IN-VIVO
   ELECTROPORATION; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS;
   GENE-TRANSFER; ADENOASSOCIATED VIRUS; TNF-ALPHA; INTRAARTICULAR
   EXPRESSION; JOINT INFLAMMATION
ER

PT J
DE RNA interference; RNA Pol II promoter; cancer therapy
ID SHORT HAIRPIN RNAS; DOUBLE-STRANDED-RNA; HUMAN-CELLS; POLYMERASE-II;
   TRANSGENE EXPRESSION; MAMMALIAN-CELLS; SHRNA LIBRARIES; IN-VITRO; GENE;
   MICRORNA
ER

PT J
ER

PT J
ID HEPATITIS-C VIRUS; SMALL INTERFERING RNAS; SHORT-HAIRPIN RNA;
   GENE-EXPRESSION; LENTIVIRAL VECTORS; TRANSGENE EXPRESSION; ANTIVIRAL
   IMMUNITY; MAMMALIAN-CELLS; HIV-1 INFECTION; POLYMERASE-II
ER

PT J
ID DOUBLE-STRANDED-RNA; SHORT HAIRPIN RNAS; MAMMALIAN-CELLS;
   MESSENGER-RNAS; STABLE EXPRESSION; STRUCTURAL BASIS; HIV-1 INFECTION;
   MODIFIED SIRNAS; NUCLEAR EXPORT; MOUSE MODEL
ER

PT J
DE atelocollagen; cancer; delivery; gene therapy; RNAi; siRNA
ER

PT J
ID IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL INTERFERING RNAS; ANTIVIRAL
   IMMUNITY; MAMMALIAN-CELLS; PROTECTS MICE; HAIRPIN RNA; STRAND RNA; TAR
   RNA; SIRNA; INHIBITION
ER

PT J
ER

PT J
DE RNAi; siRNA; atelocollagen; delivery
ID SMALL INTERFERING RNA; IN-VIVO; GROWTH-FACTOR; CANCER; THERAPEUTICS;
   TUMOR; CARCINOMA; VITRO
ER

PT J
DE RNA interference; short hairpin RNA; hydrodynamic delivery;
   electroporation; tumor growth
ID DOUBLE-STRANDED-RNA; PLASMID DNA; CLINICAL-RESEARCH; MAMMALIAN-CELLS;
   MESSENGER-RNA; INTERFERENCE; EXPRESSION; GROWTH; VITRO; ADENOCARCINOMA
ER

PT J
ID INTERFERENCE
ER

PT J
DE RNA interference; gene therapy; gene delivery; therapeutic RNAi;
   transkingdom RNA interference
ID IN-VIVO; MAMMALIAN-CELLS; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA;
   SYSTEMIC APPLICATION; ADULT MICE; SIRNA; INHIBITION; CANCER; THERAPY
ER

PT J
DE RNA interference; virus infection; virus-host interaction
ID SARCOMA-ASSOCIATED HERPESVIRUS; HIV-1 INFECTION; CAENORHABDITIS-ELEGANS;
   TYPE-1 REPLICATION; ANTIVIRAL DEFENSE; HUMAN-CELLS; T-CELLS; INHIBITION;
   MICRORNA; EXPRESSION
ER

PT J
DE RNAi; cancer gene therapy; strategy
ID SMALL INTERFERING RNA; MAMMALIAN-CELLS; ONCOLYTIC ADENOVIRUS;
   DOWN-REGULATION; TUMOR-CELLS; IN-VIVO; EXPRESSION; VECTORS; SYSTEM;
   SUPPRESSION
ER

PT J
DE polyglutamine; Huntington disease; DARPP-32; adeno-associated virus;
   RNAi
ID RNA INTERFERENCE; TRANSGENIC MICE; DECREASED EXPRESSION; MOTOR
   DYSFUNCTION; MAMMALIAN-CELLS; POLYGLUTAMINE; AGGREGATION; SURVIVAL;
   PROTEIN; NEURODEGENERATION
ER

PT J
ID IMMUNODEFICIENCY-VIRUS TYPE-1; SHORT-INTERFERING RNAS; SHORT HAIRPIN
   RNA; MAMMALIAN-CELLS; MEDIATED INHIBITION; DIRECTED INHIBITION;
   GENE-EXPRESSION; DENDRITIC CELLS; SIRNA; REPLICATION
ER

PT J
ID AGOUTI-RELATED PROTEIN; SHORT-INTERFERING RNA; PHOSPHOENOLPYRUVATE
   CARBOXYKINASE GTP; MELANOCYTE-STIMULATING HORMONE; IMPROVES INSULIN
   SENSITIVITY; HEPATITIS-B-VIRUS; GENE-EXPRESSION; IN-VIVO; COREPRESSOR
   RIP140; MAMMALIAN-CELLS
ER

PT J
DE RNA interference (RNAi); short interfering RNA (siRNA); cancer therapy;
   oncogene; apoptosis
ID DOUBLE-STRANDED-RNA; GROWTH IN-VITRO; LUNG ADENOCARCINOMA CELL; MEDIATED
   DOWN-REGULATION; SMALL INHIBITORY RNA; KAPPA-B ACTIVATION;
   GENE-EXPRESSION; CARCINOMA-CELLS; BREAST-CANCER; TUMOR-GROWTH
ER

PT J
DE RNAi; RNA interference; siRNA; antiviral; resistance; escape
ID SMALL INTERFERING RNAS; HEPATITIS-C VIRUS; SHORT HAIRPIN RNAS;
   GENE-EXPRESSION; HUMAN-CELLS; DRUG-RESISTANCE; MAMMALIAN-CELLS; HIV-1
   INFECTION; IN-VIVO; B-VIRUS
ER

PT J
DE dicer inhibition; HIV-1; RNA interference; siRNA delivery; viral escape
ID IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL INTERFERING RNAS; T-CELLS;
   HEMATOPOIETIC-CELLS; MEDIATED DELIVERY; GENE-THERAPY; IN-VIVO; TAR RNA;
   INHIBITION; REPLICATION
ER

PT J
DE RNA interference (RNAi); short interfering RNA (siRNA); delivery; human
   gene therapy
ID SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; ADENOASSOCIATED VIRUS
   VECTORS; FAS PROTECTS MICE; MAMMALIAN-CELLS; IN-VIVO; LENTIVIRAL
   VECTORS; MESSENGER-RNA; EFFICIENT TRANSDUCTION; CAENORHABDITIS-ELEGANS
ER

PT J
ID SMALL INTERFERING RNAS; DOUBLE-STRANDED-RNA; POLYGLUTAMINE-INDUCED
   NEURODEGENERATION; SCA1 TRANSGENIC MICE; HUNTINGTONS-DISEASE;
   ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MESSENGER-RNA;
   MOUSE MODEL
ER

PT J
DE RNA interference; small interfering RNA; microRNA; cancer; tumor
   development; tumor progression; gene therapy; cancer therapy
ID DOUBLE-STRANDED-RNA; RECEPTOR TYROSINE KINASE; MAMMALIAN-CELLS;
   GENE-EXPRESSION; IN-VIVO; MOLECULAR-BIOLOGY; MYELOID-LEUKEMIA; SIRNA
   SEQUENCES; CARCINOMA-CELLS; MESSENGER-RNA
ER

PT J
ID AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE;
   MOUSE MODEL; GENES; ALLELE; MICRORNAS; STRATEGY; MYOPATHY; DELIVERY
ER

PT J
DE RNA interference; siRNA; microRNA; gene silencing; gene therapy
ID DOUBLE-STRANDED-RNA; DISEASE GENES; CAENORHABDITIS-ELEGANS; MICROARRAY
   ANALYSIS; ALZHEIMERS-DISEASE; MAMMALIAN NEURONS; NERVOUS-SYSTEM; MOUSE
   MODEL; BRAIN; MICRORNAS
ER

PT J
DE RNA interference; small interfering RNA; gynecologic cancer; ovarian
   cancer
ID FUNCTIONAL GENOMIC ANALYSIS; HUMAN OVARIAN-CANCER; DOUBLE-STRANDED-RNA;
   HEPATITIS-B-VIRUS; IN-VIVO; CAENORHABDITIS-ELEGANS; DELIVERY VECTORS;
   GROWTH-FACTOR; SIRNA; CELLS
ER

PT J
ER

PT J
DE age-related macular degeneration; ocular diseases; respiratory diseases;
   respiratory syncytial virus; RNA interference; RNAi; therapeutics
ID GENE; MECHANISM; SIRNAS
ER

PT J
ID DOUBLE-STRANDED-RNA; HEPATITIS-B-VIRUS; FAS PROTECTS MICE; GENE-THERAPY;
   IN-VIVO; MAMMALIAN-CELLS; MESSENGER-RNA; INHIBITION; SIRNA; REPLICATION
ER

PT J
DE cancer; gene therapy; RNAi; siRNA
ID RNA INTERFERENCE; SUPPRESSION; INHIBITION; CELLS; GENE
ER

PT J
ID LONG TERMINAL REPEAT; MAMMALIAN-CELLS; LENTIVIRAL VECTOR; MEDIATED
   INHIBITION; HIV-1 REPLICATION; TRANS-ACTIVATION; GENE-THERAPY;
   ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; TAT TRANSACTIVATION
ER

PT J
DE RNA interference; Neurodegeneration; Reverse genetics; Gene silencing;
   Transgenic mice; Gene therapy; Huntington's disease; Alzheimer's
   disease; Parkinson's disease
ER

PT J
ER

PT J
DE RNA interference; oncogene; chemotherapy; viral suppressor;
   small-interfering RNAs (siRNAs)
ID DOUBLE-STRANDED-RNA; GENE-EXPRESSION; CARCINOMA-CELLS;
   MULTIDRUG-RESISTANCE; LEUKEMIC-CELLS; CANCER-CELLS; INHIBITION; THERAPY;
   ELEGANS; SIRNA
ER

PT J
DE gene silencing; gene therapy; RNA interference; transplantation
ID HUMAN DENDRITIC CELLS; MAMMALIAN-CELLS; HIV-1 INFECTION; CANCER CELLS;
   ADULT MICE; IN-VITRO; T-CELLS; ALLOGRAFT-REJECTION; MEDIATED DELIVERY;
   MOUSE MODEL
ER

PT J
DE gene therapy; HIV-1; RNA interference
ID VIRUS TYPE-1 REPLICATION; DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; HIV-1
   INFECTION; GENE-EXPRESSION; INHIBITION; REQUIREMENTS; SUPPRESSION;
   TRANSCRIPTS; RIBOZYMES
ER

PT J
DE blood-brain barrier; epidermal growth factor receptor; insulin receptor;
   liposomes; transferrin receptor
ID HUMAN INSULIN-RECEPTOR; IN-VIVO; MONOCLONAL-ANTIBODY; ANTISENSE GENE;
   DNA COMPLEX; EXPRESSION; DELIVERY; BARRIER; CELLS; PRIMATE
ER

PT J
DE RNAi; siRNA; shRNA; HIV-1; PTGS
ID DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; GENE-EXPRESSION; LENTIVIRAL
   VECTORS; HAIRPIN RNAS; INHIBITION; INFECTION; VIRUS; MICE; SUPPRESSION
ER

PT J
DE molecular oncology; RNA interference
ID HUMAN BREAST-CANCER; DOUBLE-STRANDED-RNA; GENE-EXPRESSION; HUMAN-CELLS;
   MAMMALIAN-CELLS; CARCINOMA CELLS; IN-VIVO; STABLE EXPRESSION; SURVIVIN
   GENE; TUMOR-CELLS
ER

PT J
DE gene silencing; gene therapy; post-transcriptional gene silencing; PTGS;
   RNAi; RNA interference; siRNA; small interfering RNA
ID SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; FUNCTIONAL GENOMIC ANALYSIS;
   CULTURED-MAMMALIAN-CELLS; RECOMBINANT HUMAN DICER; GERM-LINE
   DEVELOPMENT; SMALL TEMPORAL RNAS; HUMAN CANCER-CELLS; VECTOR-BASED RNAI;
   C-ELEGANS
ER

PT J
DE anticancer therapeutics; human cervical cancer; oncogenic viruses; RNA
   interference; RNAi therapy
ID HUMAN-PAPILLOMAVIRUS TYPE-16; GERM-LINE DEVELOPMENT; C-ELEGANS;
   CAENORHABDITIS-ELEGANS; MAMMALIAN-CELLS; GENE-EXPRESSION; MESSENGER-RNA;
   SIRNA; E6; PROTEIN
ER

PT J
DE RNA interference (RNAi); RNA, small interfering (siRNA); microRNAs
   (miRNA); small hairpin RNA (shRNA); mRNA degradation; translation;
   functional genomics; gene therapy
ID DOUBLE-STRANDED-RNA; VIRUS TYPE-1 REPLICATION; HEPATITIS-B-VIRUS;
   VECTOR-BASED RNAI; MAMMALIAN-CELLS; CAENORHABDITIS-ELEGANS;
   GENE-EXPRESSION; C-ELEGANS; HIV-1 INFECTION; ANTISENSE RNA
ER

EF